EHRA Premium Access

Late Breaking Clinical Trials

Event: EHRA 2021
Topic: Arrhythmias, General
Session type: Late-Breaking Science
Date: 23 April 2021
Time: 17:55 - 18:50

Session

4 presentations in this session

Targeted therapy of underlying conditions in patients with persistent atrial fibrillation and mild to moderate stable heart failure: long term outcome of the RACE 3 Trial

Speaker: Professor M. Rienstra (Groningen, NL)
Thumbnail

Benefits of systematic screening for Atrial Fibrillation - the STROKESTOP-study

Speaker: Doctor E. Svennberg (Stockholm, SE)
Thumbnail

Long term efficacy and final outcomes of the subcutaneous implantable cardioverter-defibrillator registry

Speaker: Professor P. Lambiase (London, GB)
Thumbnail

Early treatment of atrial fibrillation for stroke prevention trial

Speaker: Doctor A. Metzner (Hamburg, DE)
Thumbnail

4 speakers from this session

Professor Michiel Rienstra

University Medical Center Groningen, Groningen (Netherlands (The))
9 presentations
0 follower

Doctor Emma Svennberg

Karolinska Institute, Stockholm (Sweden)
11 presentations
4 followers

Professor Pier Lambiase

University College London, London (United Kingdom of Great Britain & Northern Ireland)
12 presentations
0 follower

Doctor Andreas Metzner

University Heart & Vascular Center Hamburg, Hamburg (Germany)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk